[与败血症相关的急性损伤生物标志物的研究进展]
Jiangming Zhang1,2, Minjun Qi2,3, Lumei Ma1,2
1The First Clinical Medical College of Gansu University of Traditional Chinese Medicine, Lanzhou 730030, Gansu, China.
Zhonghua wei zhong bing ji jiu yi xue
|December 19, 2024
概括
与败血症相关的急性损伤 (SA-AKI) 的早期诊断至关重要. 新的血液和尿液生物标志物有望改善SA-AKI的检测和治疗,潜在地降低成本并改善患者的治疗结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 关键护理医学 关键护理医学
- 生物标志物发现发现
背景情况:
- 败血症相关的急性损伤 (SA-AKI) 是败血症的一种普遍且严重的并发症.
- 随着SA-AKI的发病率和死亡率的上升,造成了重大的经济和社会负担.
- 目前SA-AKI的诊断方法,依赖于尿量和血清肌素,往往会延迟和不可靠.
研究的目的:
- 审查现有的和新的生物标志物,以便早期诊断和有效管理SA-AKI.
- 在SA-AKI中探索新兴生物标记物的临床实用性,例如解蛋白2 (UCP2),Sestrin 2和pannexin 1 (PANX1).
- 为推进SA-AKI诊断和治疗策略提供参考.
主要方法:
- 关于SA-AKI生物标志物的当前文献的全面审查.
- 验证的损伤前,损伤和功能生物标志物的分析.
- 探索新发现的生物标志物,包括UCP2,Sestrin2和PANX1.
主要成果:
- 传统的SA-AKI诊断在及时性和准确性方面存在局限性.
- 一系列生物标志物,分为损伤前,损伤和功能,已被确定和验证.
- 新兴的生物标志物如UCP2,Sestrin2和PANX1显示出改善SA-AKI诊断和向治疗的潜力.
结论:
- 早期发现SA-AKI对于改善患者预后和降低医疗保健成本至关重要.
- 新型生物标志物为克服当前诊断方法的局限性提供了一个有希望的途径.
- 对UCP2,Sestrin2和PANX1的进一步研究可以显著提高SA-AKI管理.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
100
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
100
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
57
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
57